ALLMedicine™ Type 2 Diabetes Center

Sep 25th, 2020 - Pregnant women with gestational diabetes mellitus (GDM) or type 2 diabetes mellitus (T2DM) are at increased risks of pre-term labor, hypertension and preeclampsia. In this study, metabolic profiling of blood samples collected from GDM, T2DM and co...

Sep 25th, 2020 - Pharmacologic Glycemic Management of Type 2 Diabetes in Adults: 2020 Update.|2020| ,Lipscombe L,Butalia S,Dasgupta K,Eurich DT,|

Sep 25th, 2020 - Pharmacologic Glycemic Management of Type 2 Diabetes in Adults: 2020 Update - The User's Guide.|2020| ,Senior PA,Houlden RL,Kim J,Mackay D,|

Sep 25th, 2020 - Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are an established treatment for patients with type 2 diabetes (T2D). Differences between GLP-1RAs in pharmacokinetics, dosing regimens and clinical effects, including cardiovascular (CV) outcom...

Sep 25th, 2020 - Insulin resistance (IR) is the most common pathophysiological change in patients with type 2 diabetes mellitus (T2DM). Several recent studies have suggested that the gut microbiome and microbial metabolites are involved in the pathogenesis of IR. ...

Aug 10th, 2020 - 2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes: A Report of the American College of Cardiology Solution Set Oversight Committee.|2020|Das SR,Everett BM,Birtcher KK,Brown...

Aug 2nd, 2020 - We examined risk of incident type 2 diabetes mellitus (T2DM) among RA patients versus four different comparison cohorts.

Mar 30th, 2020 - New American Diabetes Association (ADA)/European Association for the Study of Diabetes (EASD) guidelines for the pharmacotherapy of type 2 diabetes: Placing them into a practicing physician's perspective.|2020|Katsiki N,Ferrannini E,Mantzoros C,|d...

Mar 2nd, 2020 - There is a general consensus that overconsumption of sugar-sweetened beverages contributes to the prevalence of obesity and related comorbidities such as type 2 diabetes (T2D). Whether a similar relationship exists for no- or low-calorie “diet” dr...

Dec 18th, 2019 - The American Diabetes Association and the European Association for the Study of Diabetes have briefly updated their 2018 recommendations on management of hyperglycemia, based on important research findings from large cardiovascular outcomes trials...

Sep 25th, 2020 - Pregnant women with gestational diabetes mellitus (GDM) or type 2 diabetes mellitus (T2DM) are at increased risks of pre-term labor, hypertension and preeclampsia. In this study, metabolic profiling of blood samples collected from GDM, T2DM and co...

Sep 25th, 2020 - Pharmacologic Glycemic Management of Type 2 Diabetes in Adults: 2020 Update.|2020| ,Lipscombe L,Butalia S,Dasgupta K,Eurich DT,|

Sep 25th, 2020 - Pharmacologic Glycemic Management of Type 2 Diabetes in Adults: 2020 Update - The User's Guide.|2020| ,Senior PA,Houlden RL,Kim J,Mackay D,|

Sep 25th, 2020 - Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are an established treatment for patients with type 2 diabetes (T2D). Differences between GLP-1RAs in pharmacokinetics, dosing regimens and clinical effects, including cardiovascular (CV) outcom...

Sep 25th, 2020 - Insulin resistance (IR) is the most common pathophysiological change in patients with type 2 diabetes mellitus (T2DM). Several recent studies have suggested that the gut microbiome and microbial metabolites are involved in the pathogenesis of IR. ...

Aug 2nd, 2020 - We examined risk of incident type 2 diabetes mellitus (T2DM) among RA patients versus four different comparison cohorts.

Mar 23rd, 2020 - PHOENIX – Lower baseline fitness and greater decline in fitness over time are independently associated with a higher risk of heart failure in patients with diabetes, results from a large analysis showed. Doug Brunk/MDedge News Dr.

Mar 18th, 2020 - The Food and Drug Administration has approved safety labeling changes to all sodium-glucose transporter 2 (SGLT2) inhibitors used to treat high blood sugar in patients with type 2 diabetes. The new changes affect canagliflozin, dapagliflozin, empa.

Mar 18th, 2020 - Patients with both type 2 diabetes and asthma who were on glucagonlike peptide receptor–1 (GLP-1R) agonists for glucose control had lower levels of a key biomarker of airway inflammation than similar patients on other types of glucose-control medi.

Mar 13th, 2020 - Several risk factors, including smoking, a previous severe hypoglycemic event, and poorly functioning kidneys, can lead to vision loss in patients with type 2 diabetes, according to new findings published in the Journal of Diabetes and its Complic.